Podcast Episodes
Back to Search
AbbVie, ADCs and the future of cancer care
Antibody drug conjugates, or ADCs, are still holding on to their spot as one of the hottest areas in cancer care—and AbbVie, like many of its peers, …
1 year ago
Inside Fierce Medtech's Fierce 15
Every year, the Fierce Medtech team highlights 15 standout companies that are pushing the boundaries of innovation in medical technology. From reinve…
1 year ago
Inside ASCO 2025: Big data drops and a towering campaign
Each year, the American Society of Clinical Oncology annual meeting brings together the biggest names and brightest minds in cancer research, and thi…
1 year, 1 month ago
Forging the future of cell therapy: Bayer and BlueRock’s unique journey (Sponsored)
In this episode of The Top Line, Fierce Biotech’s Chris Hayden sat down with Dr. Juergen Eckhardt of Bayer and Dr. Seth Ettenberg of BlueRock Therape…
1 year, 1 month ago
Science-led storytelling takes center stage in pharma communications (Sponsored)
In the latest episode of The Top Line podcast, host Heath Clendenning interviews Cheryl Lubbert, CEO of Reverba Global, to discuss how science-led st…
1 year, 1 month ago
Biopharma briefing: Q1 trends, gene therapy updates and ASCO preview
Despite the long holiday weekend, news in biopharma never slows down.
In this week’s episode of "The Top Line," the Fierce team breaks down some of t…
1 year, 1 month ago
A Fierce breakdown of the 'most favored nation' executive order
President Donald Trump put the pharmaceutical industry on notice early Monday with the signing of his "most favored nation" (MFN) executive order on …
1 year, 1 month ago
Angela Hwang on her pivot from Big Pharma to biotech
Angela Hwang spent nearly three decades at Pfizer before joining Flagship Pioneering in 2025 as a CEO-partner and the CEO of Metaphore Biotechnologie…
1 year, 2 months ago
ElevAAte and the push for East Asian American leaders in biopharma
Although East Asians make up a significant share of entry-level roles in U.S. biopharma, few have risen to senior leadership positions. That disparit…
1 year, 2 months ago
Angus on Angus: A Fierce oncology discussion
We’ve known for a while that there are two Anguses—both journalists covering oncology at health- and biopharma-focused news outlets. Now, for the fir…
1 year, 2 months ago